This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2014 Oct 16;371(16):1547-8.

doi: 10.1056/NEJMcibr1409796.

The target of metformin in type 2 diabetes

PMID: 25317875
DOI: 10.1056/NEJMcibr1409796

The target of metformin in type 2 diabetes

Ele Ferrannini. N Engl J Med. 2014.

. 2014 Oct 16;371(16):1547-8.

doi: 10.1056/NEJMcibr1409796.

Author

PMID: 25317875
DOI: 10.1056/NEJMcibr1409796

No abstract available

PubMed Disclaimer

Similar articles

Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase.
Madiraju AK, Erion DM, Rahimi Y, Zhang XM, Braddock DT, Albright RA, Prigaro BJ, Wood JL, Bhanot S, MacDonald MJ, Jurczak MJ, Camporez JP, Lee HY, Cline GW, Samuel VT, Kibbey RG, Shulman GI. Madiraju AK, et al. Nature. 2014 Jun 26;510(7506):542-6. doi: 10.1038/nature13270. Epub 2014 May 21. Nature. 2014. PMID: 24847880 Free PMC article.
Molecular action of metformin in hepatocytes: an updated insight.
Sliwinska A, Drzewoski J. Sliwinska A, et al. Curr Diabetes Rev. 2015;11(3):175-81. doi: 10.2174/1573399811666150325233108. Curr Diabetes Rev. 2015. PMID: 25808533 Review.
Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilization in a non-obese type 2 diabetes Goto-Kakizaki rats.
Yoshida T, Okuno A, Tanaka J, Takahashi K, Nakashima R, Kanda S, Ogawa J, Hagisawa Y, Fujiwara T. Yoshida T, et al. Eur J Pharmacol. 2009 Nov 25;623(1-3):141-7. doi: 10.1016/j.ejphar.2009.09.003. Epub 2009 Sep 15. Eur J Pharmacol. 2009. PMID: 19765581
Current understanding of metformin effect on the control of hyperglycemia in diabetes.
An H, He L. An H, et al. J Endocrinol. 2016 Mar;228(3):R97-106. doi: 10.1530/JOE-15-0447. Epub 2016 Jan 7. J Endocrinol. 2016. PMID: 26743209 Free PMC article. Review.
Metformin's Therapeutic Efficacy in the Treatment of Diabetes Does Not Involve Inhibition of Mitochondrial Glycerol Phosphate Dehydrogenase.
MacDonald MJ, Ansari IH, Longacre MJ, Stoker SW. MacDonald MJ, et al. Diabetes. 2021 Jul;70(7):1575-1580. doi: 10.2337/db20-1143. Epub 2021 Apr 13. Diabetes. 2021. PMID: 33849997

See all similar articles

Cited by

Fixed-Dose Combination of Canagliflozin and Metformin for the Treatment of Type 2 Diabetes: An Overview.
Davidson JA, Sloan L. Davidson JA, et al. Adv Ther. 2017 Jan;34(1):41-59. doi: 10.1007/s12325-016-0434-2. Epub 2016 Nov 16. Adv Ther. 2017. PMID: 27854055 Free PMC article. Review.
Metformin ameliorates the severity of experimental Alport syndrome.
Omachi K, Kaseda S, Yokota T, Kamura M, Teramoto K, Kuwazuru J, Kojima H, Nohara H, Koyama K, Ohtsuki S, Misumi S, Takeo T, Nakagata N, Li JD, Shuto T, Suico MA, Miner JH, Kai H. Omachi K, et al. Sci Rep. 2021 Mar 29;11(1):7053. doi: 10.1038/s41598-021-86109-1. Sci Rep. 2021. PMID: 33782421 Free PMC article.
Safety of metformin continuation in diabetic patients undergoing invasive coronary angiography: the NO-STOP single arm trial.
Chiarito M, Sanz-Sanchez J, Piccolo R, Condello F, Liccardo G, Maurina M, Avvedimento M, Regazzoli D, Pagnotta P, Garcia-Garcia HM, Mehran R, Federici M, Condorelli G, Diez Gil JL, Reimers B, Ferrante G, Stefanini G. Chiarito M, et al. Cardiovasc Diabetol. 2023 Feb 6;22(1):28. doi: 10.1186/s12933-023-01744-4. Cardiovasc Diabetol. 2023. PMID: 36747244 Free PMC article. Clinical Trial.
The effect of metformin on vitamin B12 level in pediatric patients.
Yu YM, So SKC, Khallouq BB. Yu YM, et al. Ann Pediatr Endocrinol Metab. 2022 Sep;27(3):223-228. doi: 10.6065/apem.2142210.105. Epub 2022 May 16. Ann Pediatr Endocrinol Metab. 2022. PMID: 35592896 Free PMC article.
Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation.
Leidgens V, Proske J, Rauer L, Moeckel S, Renner K, Bogdahn U, Riemenschneider MJ, Proescholdt M, Vollmann-Zwerenz A, Hau P, Seliger C. Leidgens V, et al. Oncotarget. 2017 Jan 31;8(5):8250-8263. doi: 10.18632/oncotarget.14159. Oncotarget. 2017. PMID: 28030813 Free PMC article.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information